The incidence and biochemical patterns of Streptococcus suis capsular types 9-22 are presented. Of 148 untypeable (with types 1-8 antisera) isolates of S. suis recovered from diseased pigs, 10% were not capsulated. Of the remaining 134 isolates, only 53% belonged to capsular types 9-22; capsular types 22 and 9 were the most prevalent, representing 19% and 13%, respectively. Capsular type 15 (de Moor's group T Streptococcus) is reported here for the first time in North America since it was described in 1963 in Europe. Of 188 untypeable isolates recovered from clinically healthy pigs, 25% were noncapsulated. Of the remaining 141 isolates, 90% belonged to the new capsular types, and 87% were identified as 1 of 4 types: 17, 18, 19, and 21. Capsular types 12 and 20 were not detected among the Canadian isolates. Almost half of strains were arginine dihydrolase-negative, and 45% fermented mannitol, which is seldom a positive test with capsular types l-8. Although some strains were negative with salicin or trehalose, none were negative for both sugars. Only 54% of isolates tested with 1 rapid multitest system were correctly identified as S. suis. A tentative biochemical profile that might be used with a microplate identification system is also presented. Biochemical identification using the conventional system instead of the rapid multitest system is preferable.
Streptococcus suis infection in swine is common in all countries where hog production is well developed. This infection has been associated with bronchopneumonia, meningitis, arthritis, pericarditis, myocarditis, endocarditis, fibrinous polyserositis, septicemia, rhinitis, and abortion. 3, 4, 6, 9, 22, 31, 34, 35 Streptococcus suis has also been described as a pathogen for ruminants 12, 14, 17 and humans. 2, 28 In 1983, 9 capsular types of S. suis were recognized. 30 Among them, type 2 was most frequently associated with infectious processes in North American pigs. 9, 15, 33, 35 Subsequently, several untypeable isolates were recovered from diseased and clinically healthy pigs by many investigators. [5] [6] [7] 15, 34, 35 Fourteen new capsular types have been described, 12 but until now no epidemiologic data concerning their prevalence were available. Moreover, the biochemical patterns had never been compared with those of previously identified capsular types, and it was not known if identification of these new capsular types could be achieved by the rapid identification systems currently used for S. suis. 7, 16, 22, 34 The purposes of this study were to determine the incidence of capsular types 9-22 among untypeable (with types l-8 antisera) S. suis isolates and to compare the biochemical patterns with those of previously iden-tified capsular types, using conventional tests, a rapid multitest system, and a microplate identification system. These isolates were recovered from diseased pigs affected with a variety of syndromes and from the nasal cavities of clinically healthy pigs.
Materials and methods
Bacterial strains. Streptococcus suis types 9-22 reference strains were used. 12 One hundred forty-eight S. suis isolates recovered from diseased pigs and untypeable with capsular types l-8 antisera and 188 other untypeable isolates collected from the nasal cavities of clinically healthy pigs were studied. Isolates from diseased pigs were obtained in 1988 and 1989 from different diagnostic laboratories in Quebec, Canada, and forwarded for further examination because they had been recovered in pure culture or as the predominant organism from porcine tissues. Culture of tissues was carried out on 5% bovine blood agar plates" incubated at 37 C with 5% CO, for 24 hr. Isolates from the nasal cavities of clinically healthy pigs were recovered on bovine blood agar plates containing Streptococcus-selective supplement b incubated at 37 C for 24 hr. The isolates had been kept lyophilized since 1986. For the biochemical identification, 33 other typeable strains of S. suis were used. c These strains belonged to the following capsular types: 9 (8 strains), 10 (6 strains), 11 (4 strains), 12 (2 strains), 13 (2 strains), 14 (2 strains), 15 (8 strains), and 16 (1 strain). Finally, 98 strains belonging to types l-8 and l/2 and previously identified with the conventional system were used for the evaluation of the microplate identification system.
Capsular typing. Only capsulated strains with homogeneous growth in Todd-Hewitt brotha were typed. 29 Antisera were raised in rabbits against all reference strains as described earlier. 23 The coagglutination test, carried out as described, 24 was used as a screening test. Weak or multiple positive reactions were confirmed by the capsular reaction and the capillary precipitation tests. 13, 23, 30 Antisera against capsular types 2, 6, and 16 were absorbed as described. 12 Isolates were also examined for the presence of group D antigen, using a commercial reagent for coagglutination d following the manufacturer's recommendations.
Biochemical identification. All capsulated isolates and reference strains were subjected to 10 of the following conventional biochemical tests: 5, 9, 13, 15 hydrolysis of arginine, Voges-Proskauer test, and production of acid from various carbohydrates (inulin, salicin, trehalose, lactose, sucrose, sorbitol, mannitol, and glycerol). The strains were also tested for their ability to grow in the presence of 6.5% NaCl. a Acid production was tested in Phenol Red broth," and reading was carried out after 48 hr of incubation at 37 C under aerobic conditions. When differentiation between S. suis and S. pneumoniae was necessary, sensitivity to optochin was checked by inoculating a young culture on Mueller-Hinton agar, and commercial discs a were used according to the manufacturer's recommendations. Reference strains and 123 typeable isolates of S. suis chosen at random and recovered from diseased as well as clinically healthy pigs were tested with a rapid multitest system, e following the manufacturer's recommendations. Ninety-five randomly chosen isolate types 9-22 and 98 types 1-8 and 1/2 strains were tested with a microplate identification system. f Only biochemical data were collected with this system; a direct recognition of S. suis was not expected because the software was not programmed for the identification of S. suis.
Results

Capsular typing.
Of the 148 isolates recovered from diseased pigs, 14 (10%) were noncapsulated and untypeable with all known antisera and, therefore, were not examined further. Of the remaining 134 isolates, only 70 (53%) belonged to 11 of the new capsular types ( Table 1) . Among them, capsular types 22 (19%) and 9 (13%) were the most prevalent, followed by types 16 and 18, representing 4.5% and 4%, respectively. None of the isolates could be identified as capsular type 21. Sixty-three capsulated isolates (47%), biochemically identified as S. suis, did not belong to any of the known capsular types of S. suis.
Of the 188 isolates recovered from the nasal cavities of clinically healthy pigs, 47 (25%) were noncapsulated and, obviously, untypeable with current antisera. Of the 141 remaining isolates, 123 (87%) belonged to the new capsular types 21 (35%), 19 (22%), 18 (17%), and 17 (13%) ( Table 1) . Two isolates of type 16, 1 of type 22, and 1 of type 9 were also found. The remaining 14 isolates (10%) were untypeable. None of the 275 Canadian isolates originating from both groups of animals belonged to capsular types 12 or 20.
Multiple cross-reactions were obtained using the coagglutination test, especially with isolates of capsular Biochemical identzjkation. Results of the biochemical tests of isolate types 9-22 recovered from diseased and clinically healthy pigs (reference strains as well as strains from Denmark) are shown in Table 2 and are compared with expected results for capsular types l-8 according to current literature. No biochemical pattern was associated with any particular capsular type. Almost half of the strains were arginine dihydrolase negative, regardless of capsular type. Despite an average of 86% positive result with the inulin fermentation test, 66% of type 22 strains were inulin negative. One hundred ten (45%) typeable strains fermented mannitol. These strains belonged to capsular types 9, 17, 18, 19, and 21, with 3.5%, 73%, 53%, 88.5%, and 91% positive reaction for each capsular type, respectively. Five capsular type 17 strains and two capsular type 21 strains also fermented Sorbitol. Some strains were salicin or trehalose negative (12.5% and 5%, respectively). All strains tested fermented at least 1 of these sugars. All untypeable (with types 1-22 antisera) isolates were considered S. suis because they presented a general biochemical profile.
Results of the biochemical tests with the rapid multitest system are shown in Table 3 . Some tests gave results different than expected. The ß-glucuronidase test was positive only for 65% of the strains. All 16 capsular type 22 strains, 11 of 20 capsular type 9 strains, 10 of 15 capsular type 21 strains and the only capsular test. Some strains belonging to other capsular types were also negative. This test was critical because all as well as sorbitol-positive strains (4%) were also de-these strains were identified as S. pneumoniae by the rapid multitest system index. Nevertheless, all these tected, and some strains were glycogen and starch neg-strains were resistant to optochin, to which only strains ative (18 and 13%, respectively). The pyrrolidonylarylamidase test was positive for 49% of strains tested. Twenty-four strains that were negative for arginine Discussion dihydrolase in the conventional test were positive when tested with the rapid multitest system. Of the 137 strains tested with the rapid multitest system, only 74 (54%) were identified as S. suis. Of these, 2 type 9 strains were characterized as "doubtful." The number of strains of each capsular type tested and identified as S. suis is presented in Table 4 .
After the description of 6 new capsular types in 1983, 30 a large number of suis isolates recovered from diseased and clinically healthy pigs were untypeable with available antisera. More recently, we described 14 new capsular types; most reference strains originated from tissues of diseased pigs, but others were recovered from the nasal cavities of clinically healthy Results of the biochemical identification of S. suis using a microplate identification system appear in Table 5 . There were no striking differences between types l-8 and types 9-22. The percentage of strains of capsular types l-8 positive for fermentation of cellobiose was higher (95%) than that for the new capsular types (71%). Several mannitol-positive strains were also detected among the new capsular types, and the arginine dyhidrolase test gave variable results for all capsular types. Most S. suis strains were bile-esculin negative, and some strains grew in the presence of potassium tellurite.
Group D antigens could not be detected in 28 strains belonging to capsular types 9, 10, 15, 17, 18, and 19. Table 4 . Identification of S. suis capsular types 9-22 with the rapid multitest system. Table 5 . Results of the microplate identification system for identification of S. suis strains. pigs. One reference strain was isolated from a diseased calf (capsular type 20) and another from a case of human meningitis (capsular type 14). 12 Among the unofficial new capsular types existing in 1987, capsular types 9, 15, and 10 were the most frequently found (Henrichsen J: 1987, Xth Lancefield Int Symp Streptococci and Streptococcal Dis). In 1988, 2 strains of capsular types 10 and 11 were isolated from the tonsils of healthy fatteners in a slaughterhouse. 34 In western Canada, an outbreak of lethal infections in 7-week-old piglets was recently associated with S. suis capsular type 9. 25 In the present study, we have worked with all capsular types described in the literature. Among isolates originating from diseased pigs, capsular types 22 and 9 were the most common. Only 1 isolate of each of these capsular types could be recovered from clinically healthy pigs. One capsular type 14 isolate was found in a pig with meningitis, which indicates the possible role of this S. suis type in zoonoses. 12 Two isolates belonging to capsular type 15 (de Moor's group T Streptococcus) were isolated. To our knowledge, this is the first report of the isolation of this type in North America since it was described in Europe in 1963. 8 The high proportion of remaining capsulated but untypeable isolates (47%) indicates the probable existence of additional capsular types.
In Canada, it was reported earlier that 94% of 4-8-
week-old clinically healthy piglets harbored S. suis in their nasal cavity, and that almost 80% of these isolates did not belong to capsular types 1-8. 5 Eighty-seven percent of these isolates were grouped within only 4 new capsular types (17, 18, 19, and 21) , and 10% of other isolates remained untypeable. Although strains untypeable with antisera against capsular types l-8 have been associated with the development of rhinitis in swine, 6, 34 it is not possible at this time to establish whether S. suis isolates from the nasal cavity are normal, but potentially pathogenic, inhabitants of the superior respiratory tract, although this situation appears to be very likely. The role played by S. suis in infections of pigs appears to resemble that of S. pneumoniae in infections of humans. 19 Capsular types 12 and 20, which were not isolated in the present study, have recently been recovered from diseased pigs in Canada (unpublished observations). Using the conventional system for biochemical identification, some differences among the biochemical patterns of capsular types l-8 and 9-22 were observed. Most isolates of types 17, 19, and 21 and several isolates of types 9 and 18 fermented mannitol. This positive reaction has been noted with previous capsular types by some authors, 1, 16, 21 who suggested that such strains could be considered to be S. suis. Mannitoland Sorbitol-positive strains have been isolated from ruminants. 17 In Quebec, 7 porcine strains with these characteristics were found. Several authors considered the production of acid from inulin as a variable characteristic. 16, 22, 34 Among the new capsular types, 66% of type 22 strains were positive for this test; among other types, more than 90% were positive. As was shown in this study, the 4 tests routinely used in our laboratory for presumptive identification of S. suis (Table 2) 13, 15 can be successfully used for all capsular types.
Several authors have used a rapid multitest system for the biochemical identification of S. suis. 16, 20, 22, 34 In the present study, only 54% of the capsular types 9-22 could be identified as S. suis. Among them, none of 16 capsular type 22 strains were correctly identified. All these strains, as well as some misidentified strains belonging to other capsular types, did not possess ß-glucuronidase. Other authors had already reported some similar S. suis strains. 16, 17 These strains were systematically identified as S. pneumoniae by the system, but they were resistant to optochin. The pyrrolidonylarylamidase test, which is used by the system to differentiate enterococci (which are positive) from other streptococci (except S. pyogenes), was positive for almost half of the S. suis strains examined. Growth in 6.5% NaCl used in the conventional system was more reliable for identification of enterococci. Glycogen-or starch-negative strains could also be associated with S. suis species. As proposed, 11 the rapid multitest sys-tern was more sensitive than the conventional system for detecting the hydrolysis of arginine.
Relatively homogeneous results for most tests were obtained using a microplate identification system. The profile described in Table 5 for all S. suis strains studied could be considered for future identification with this system. The arginine dihydrolase test was as sensitive as the conventional test. It has been postulated 10 that the bile-esculin test could be used as a presumptive identification of group D streptococci; in this study and using the microplate identification system, most S. suis strains were negative. Using the conventional system, others 16 have described several strains that were negative for their test. Although S. suis strains may cross-react with group D antiserum, they are not closely related to group D streptococci, 18 resulting in variation in test results. Although some authors have used the detection of group D antigen with S. suis strains, 29,32 we agree with those 16,18 who do not consider it a test of choice in the routine identification of this microorganism.
The use of the capsular reaction test instead of the capillary precipitation test is recommended for confirming results of the coagglutination test for capsular typing. Several untypeable isolates could not be included in this study because they were not capsulated. Loss of capsular material in vivo and in vitro has been reported previously, 26, 27 and it is obvious that such strains may be biochemically identified as S. suis, although they cannot be typed.
In conclusion, our study showed that most of capsular types 9-22 are present in North America, and certain of them may be commonly isolated from clinically healthy animals. The use of the conventional biochemical identification system instead of the rapid multitest system is preferable for the identification of these organisms.
